Maple Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42M Sell
171,979
-2,849
-2% -$664K 2.81% 12
2025
Q4
$36.2M Buy
174,828
+621
+0.4% +$123K 2.28% 15
2025
Q3
$32.3M Buy
174,207
+2,359
+1% +$404K 2.12% 18
2025
Q2
$26.2M Buy
171,848
+3,867
+2% +$594K 1.8% 19
2025
Q1
$27.9M Buy
167,981
+1,748
+1% +$274K 2.15% 19
2024
Q4
$24M Sell
166,233
-165
-0.1% -$25.6K 1.77% 20
2024
Q3
$27M Buy
166,398
+1,997
+1% +$318K 2.06% 19
2024
Q2
$24M Buy
164,401
+3,264
+2% +$485K 1.95% 20
2024
Q1
$25.5M Buy
161,137
+4,330
+3% +$689K 2.32% 17
2023
Q4
$24.6M Buy
156,807
+3,265
+2% +$501K 2.46% 15
2023
Q3
$23.9M Buy
153,542
+1,999
+1% +$330K 2.73% 15
2023
Q2
$25.1M Buy
151,543
+2,836
+2% +$458K 2.73% 15
2023
Q1
$23M Buy
148,707
+1,182
+0.8% +$191K 2.82% 13
2022
Q4
$26.1M Buy
147,525
+1,155
+0.8% +$199K 3.45% 10
2022
Q3
$25.2M Buy
146,370
+6,383
+5% +$1.08M 3.17% 10
2022
Q2
$24.8M Buy
139,987
+13,194
+10% +$2.35M 3.27% 9
2022
Q1
$22.5M Buy
126,793
+8,790
+7% +$1.5M 2.64% 11
2021
Q4
$20.2M Buy
118,003
+6,222
+6% +$1.02M 2.2% 19
2021
Q3
$18.1M Buy
111,781
+2,201
+2% +$376K 2.29% 16
2021
Q2
$19.3M Buy
109,580
+8,079
+8% +$1.34M 2.33% 18
2021
Q1
$16.7M Buy
101,501
+2,294
+2% +$371K 2.47% 13
2020
Q4
$15.6M Sell
99,207
-432
-0.4% -$63.8K 2.41% 15
2020
Q3
$14.9M Buy
99,639
+789
+0.8% +$117K 2.42% 14
2020
Q2
$13.9M Sell
98,850
-1,328
-1% -$194K 2.72% 11
2020
Q1
$13.1M Sell
100,178
-956
-0.9% -$136K 3.28% 8
2019
Q4
$14.8M Buy
101,134
+787
+0.8% +$107K 2.85% 8
2019
Q3
$13M Sell
100,347
-875
-0.9% -$115K 2.79% 9
2019
Q2
$14.1M Buy
101,222
+528
+0.5% +$73.1K 3.17% 8
2019
Q1
$14.1M Sell
100,694
-1,309
-1% -$175K 3.31% 8
2018
Q4
$13.2M Buy
102,003
+979
+1% +$137K 3.38% 4
2018
Q3
$14M Sell
101,024
-2,034
-2% -$270K 3.15% 6
2018
Q2
$12.5M Buy
103,058
+1,152
+1% +$144K 3.09% 5
2018
Q1
$13.1M Buy
101,906
+1,113
+1% +$150K 3.25% 5
2017
Q4
$14.1M Buy
100,793
+4,082
+4% +$569K 3.62% 4
2017
Q3
$12.6M Sell
96,711
-1,685
-2% -$223K 3.38% 4
2017
Q2
$13M Buy
98,396
+125
+0.1% +$15.9K 3.74% 3
2017
Q1
$12.2M Buy
98,271
+5,413
+6% +$647K 3.61% 3
2016
Q4
$10.7M Buy
92,858
+2,813
+3% +$325K 3.36% 3
2016
Q3
$10.6M Buy
90,045
+1,059
+1% +$128K 3.45% 1
2016
Q2
$10.8M Sell
88,986
-5,884
-6% -$669K 3.95% 1
2016
Q1
$10.3M Sell
94,870
-347
-0.4% -$35.9K 3.78% 1
2015
Q4
$9.78M Buy
95,217
+887
+0.9% +$89.2K 3.47% 2
2015
Q3
$8.81M Sell
94,330
-526
-0.6% -$50.9K 3.26% 1
2015
Q2
$9.24M Buy
94,856
+995
+1% +$99.6K 3.16% 1
2015
Q1
$9.44M Sell
93,861
-4
-0% -$407 3.28% 1
2014
Q4
$9.81M Buy
93,865
+1,229
+1% +$130K 3.55% 1
2014
Q3
$9.87M Buy
92,636
+790
+0.9% +$81.9K 3.74% 1
2014
Q2
$9.61M Sell
91,846
-135
-0.1% -$13.6K 3.5% 1
2014
Q1
$9.04M Buy
91,981
+4,914
+6% +$456K 3.49% 1
2013
Q4
$7.97M Buy
87,067
+2,846
+3% +$262K 3.18% 3
2013
Q3
$7.3M Sell
84,221
-335
-0.4% -$30.1K 3.21% 3
2013
Q2
$7.26M Buy
+84,556
New +$7.18M 3.25% 3

Other funds holding JNJ

Maple Capital Management's JNJ Position: Q1 2026 in Review

Maple Capital Management reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, selling an estimated $664K and leaving 171,979 shares worth $42M. The position accounts for 2.81% of the portfolio, ranked #12.

Maple Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Maple Capital Management held 171,979 shares of Johnson & Johnson worth $42M as of Q1 2026.
  • Maple Capital Management sold 2,849 Johnson & Johnson shares in Q1 2026, an estimated $664K.
  • Johnson & Johnson made up 2.81% of Maple Capital Management's portfolio in Q1 2026, its #12 holding.
  • Maple Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Maple Capital Management's 13F filing for Q1 2026, filed 8 May 2026.